Background: Estrogen receptors (ER) and progesterone receptors (PR) have important
prognostic value in endometrial cancer, but there is no recognized positive …

Endometrial cancer is a major cancer in women and traditionally divided into type 1 and type
2. It is well known that type 2 endometrial cancer has a poor prognosis. Studies have …

The survival of 213 postmenopausal patients with primary endometrial cancer was analyzed
as a function of clinicopathologic features and cytosol steroid receptor levels. Estrogen …

Objective In this study, 345 patients with endometrial carcinoma (EC) were selected to
investigate the correlation between ER/PR status and the EC disease-free survival (DFS) …

Objective To compare the efficiency of three different estrogen receptor (ER)
immunostaining scoring systems by analyzing the correlation between ER status and …

Abstract Background and Objectives We aimed to explore the capacity of the combined ratio
of biomarkers to predict the recurrence of Stage I–III endometrial cancer (EC). Methods A …

Aim We aimed to clarify the clinical value of P53 index in patients with early low‐risk
endometrial cancer (EC) and find an optimal cut‐off value of P53 index for predicting the …

OBJECTIVE: The estrogen receptor (ER)-alpha and-beta and progesterone receptor (PR)-A
and-B were determined in endometrioid endometrial cancer, and their prognostic values …

Background The purpose of this study was to construct a nomogram based on classical
parameters and immunohistochemical markers to predict the recurrence of early low-risk …

Purpose This study aims to determine the optimal cut-off value of Ki-67 to better predict the
recurrence of early low-risk endometrial cancer (EC). Methods Seven hundred and forty …